APP and Alzheimer disease: Combined the results that Fuzi boosts the cell projections in very low concentration, promotes the proliferation activity of cells in low to medium concentration, and causes injury of APP cells in high concentration (>100 mg/mL), we speculated that in different concentrations the core active ingredients of Fuzi might differ, and they regulate different pathways to anti-AD.